Menu
About us
About us
News
Management team
Scientific advisory board
Our partners
About Fernand Labrie
Employment
Grants & aid
Hormones & Health
Hormones & Health
Menopause
Dyspareunia
Men's Health
Treatment of Hot Flashes and Osteoporosis
Exploring Endometriosis
Blocking Breast Cancer
Intrarosa™
Research
Research
Intracrinology
Clinical Studies
Laboratory
Laboratory
Bioanalytical Services
Analytics Laboratories
R&D Services
Manufacturing
Questions?
Contact us
FR
FOCUSED ON WOMEN'S HEALTH
and hormone-sensitive cancer for healthy aging worldwide
Discover our research
Our solution
A low dose (6.5 mg) of intravaginal DHEA permits a strictly local action while maintaining all serum estrogens or androgens as well as their metabolites within normal values.
Find out about Intrarosa™
Dr. Fernand Labrie
Dr. Labrie has authored or co-authored more than 1340 scientific publications with over 50,000 citations.
Dr Fernand Labrie
Latest News
Read the news
The editors of Menopause have selected our paper, “Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause”, as the notable paper from 2016.
October 25, 2018
Life Sciences Success Conference: Endoceutics
August 22, 2018
The Galien Foundation Debuts 2018 Prix Galien USA Nominees in “Best Biotechnology Product,” “Best Pharmaceutical Product,” and “Best Medical Technology” Categories
July 26, 2018
